Equillium (EQ) Other financing activities (2020 - 2026)
Equillium's (EQ) quarterly Other financing activities came in at $448000.0 in Q1 2026, up 1078.95% year-on-year from $38000.0 in Q1 2025, and up 101.71% on a QoQ basis from -$26.3 million in Q4 2025.
Equillium (EQ) Other financing activities (2020 - 2026) Analysis & Trends
Equillium (EQ) has 7 years of Other financing activities data on file, last reported at $448000.0 in Q1 2026.
- On a quarterly basis, Other financing activities rose 1078.95% year-over-year to $448000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 7386.67% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 45800.0% from the prior year.
- Other financing activities for Q1 2026 stood at $448000.0, up from -$26.3 million in the prior quarter.
- Over the last five years, Other financing activities for EQ reached as high as $28.1 million in Q3 2025 and fell as low as -$26.3 million in Q4 2025.
- Historically, Other financing activities has averaged $335571.4 across 5 years, with a median of $73000.0 in 2022.
- Across the five-year window, Other financing activities slumped 30080.46% in 2025 and soared 1078.95% in 2026, its largest moves.
- Year by year, Other financing activities stood at $73000.0 in 2022, then gained by 8.22% to $79000.0 in 2023, then tumbled by 210.13% to -$87000.0 in 2024, then slumped by 30080.46% to -$26.3 million in 2025, then soared by 101.71% to $448000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $448000.0 in Q1 2026, -$26.3 million in Q4 2025, and $28.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 448,000.00 |
| Mar 31, 2026 | 448,000.00 |
| Dec 31, 2025 | -26.26 Mn |
| Dec 31, 2025 | -26.26 Mn |
| Sep 30, 2025 | 28.06 Mn |
| Sep 30, 2025 | 28.06 Mn |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Dec 31, 2023 | 79,000.00 |
| Dec 31, 2023 | 79,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 773,000.00 |
| Dec 31, 2021 | 773,000.00 |
| Sep 30, 2021 | -499,000.00 |
| Sep 30, 2021 | -499,000.00 |
| Jun 30, 2021 | 622,000.00 |
| Jun 30, 2021 | 622,000.00 |